PHARMACEUTICAL DOSAGE FORMS AND COMPOSITIONS OF 5-HT1A RECEPTOR ANTAGONISTS

摘要

This invention relates to, for example, novel formulations and methods for the delivery of 4-­cyano-N- {(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5 yl)-piperazin-l-yl]-propyl}-N-pyridin-2-yl­benzamide, pharmaceutically acceptable salts thereof, structurally related compounds and/or metabolites; as well as to use of these formulations and methods for treating disease.